It’s finally happening. First trading day is set for Thursday next week. Price range will be €26-30/share for up to 32.7m (+1.9m management) shares to float up to

Read More

Douglas are looking to IPO as soon as this month with a full refinancing of the cap stack. Interestingly though, CVC are planning to inject another €300m in the

Read More

The company changed its legal form from GmbH to AG - in a clear sign of

Read More

The numbers published this morning had for the most part been previously released. So there is little to sink our teeth into. The company is tracking our model

Read More

That IPO is coming. It’s not typical for Douglas to release earnings early, but those we’ve seen this morning even beat the trajectory we have been modelling. Q1 sales were right on target, but we think were

Read More

Douglas reported Q1 sales this morning right on target. We anticipate discontinuing the name as both Sr and Sub are now call constraint and

Read More

Please find our updated analysis of Douglas here. 

It marks the end of a long run. CVC, having bought and expanded the company on a reptilian roll-out strategy, had to learn to spell words like

Read More

German press is beginning to speculate on the IPO of the company in Calendar Q1 of this year. CVC have missed the boat twice and so even if this is not

Read More

Douglas EBITDA came in right on target - €2m below estimate, although on lower volumes at higher prices. This has been a theme and we will be forecasting a

Read More

Douglas have announced they will be paying cash coupons on the PIK notes for the first time. Most market participants have been looking forward to this move, but it is somewhat

Read More

18% in the bag: CVC have hired GS, DB, Citi, Unicredit and UBS to run the IPO books. We had previously dismissed the Idea that Rothschild would be advising the

Read More

Please find our updated analysis of Douglas here.

It is that time when the bet has worked out and you still believe in the upside, only your instruments will no longer participate in it as much as they used to. 11% YTM is nice, but for

Read More

Douglas reported another set of strong results, although we have to recognise differences between our model and the actuals. Volumes were lower at better prices,

Read More

Rumour is making the rounds that Douglas have appointed Rothschilds to explore a 2024 Frankfurt listing. It’s an odd rumour. On the one hand, CVC have

Read More

Please find our updated analysis here.

We’ve been bullish on this name for some time. As the business is overcoming the series of shocks it endured since CVC bought their stake - Online migration in home-market Germany, the pandemic or now the steep rise in inflation, it feels like Douglas might be

Read More

Q2 is always a dampener for Douglas, due to relatively slow business following the annual winter binge and thus seasonally outflowing WC. The company, however, exceeded

Read More

The German perfume and cosmetics retailer today announced the cornerstones of its new strategy under CEO van der Lean. As expected, it is more

Read More

Please find our updated analysis of Douglas here.

Long lead-time retailers can be a risky bet, but as long as consumers remain flush enough to afford your product, the stronger the rise in inflation, the better. Fortunately,

Read More

Told you so. The German perfume and cosmetics retailer is out with a very strong and decisive Q1. For reasons we’ve outlined before, we

Read More

Douglas have behaved as expected with sales and EBITDA back to 2019 levels. France a little softer, Germany a little stronger than expected. Total Sales were a touch higher at a

Read More